Veristat to Assist on Adaptive Enrichment Design Trial for Verastem’s Defactinib in...
Input Will Drive Trial Design for Lead Cancer Stem Cell-Targeting Program
September 10, 2013 - Veristat, a leading,...
September 10, 2013 - Veristat, a leading,...